Durham, NC, United States of America

Dong Wang

This inventor holds 1 USPTO granted patent. Top assignee: Duke University. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dong Wang

Introduction

Dong Wang is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of medical technology, particularly in the detection of age-related macular degeneration. His innovative approach utilizes machine learning to enhance diagnostic capabilities.

Latest Patents

Dong Wang holds a patent for "Systems and methods related to age-related macular degeneration." This patent describes systems that utilize machine learning to detect geographic atrophy. The system includes at least one processor, a memory, and a computing platform. It is designed to receive volumetric scan images, determine their positions, and generate a probabilistic likelihood that each scan is informative of geographic atrophy or neovascular age-related macular degeneration. The system can include high probability scans in a dataset and determine whether geographic atrophy or neovascular age-related macular degeneration is present or likely to occur.

Career Highlights

Dong Wang is affiliated with Duke University, where he continues to advance his research and innovations. His work has the potential to significantly impact the field of ophthalmology and improve patient outcomes.

Collaborations

Some of his notable coworkers include Eleonora Lad and Lawrence L Carin. Their collaborative efforts contribute to the advancement of research in the field.

Conclusion

Dong Wang's innovative work in the detection of age-related macular degeneration showcases the intersection of technology and healthcare. His contributions are paving the way for improved diagnostic methods and better patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…